| http://www.w3.org/ns/prov#value | - 20110236395TREATMENT OF FIBROTIC EYE DISORDERS USING AN MMP2 INHIBITOR - Inhibitors of matrix metalloproteinase 2 are used to treat or prevent a fibrotic disorder of the posterior capsule of the eye, for example posterior capsule opacification (PCO), or of a tissue or structure of the eye other than the lens or capsular bag.09-29-2011
|
